Takeda Pharmaceutical Company Limited - Depositary Receipt (Common Stock)
DE ˙ DB ˙ US8740602052
12,80 € ↓ -0,10 (-0,78%)
2026-06-04
AKTIENPREIS
SecurityDE:TKDA / Takeda Pharmaceutical Company Limited - Depositary Receipt (Common Stock)
InstitutionPrivate Advisor Group, LLC
Latest Disclosed Ownership26,488 shares
Latest Disclosed Value $ 490,543
Private Advisor Group, LLC reports 17.22% increase in ownership of TKDA / Takeda Pharmaceutical Company Limited - Depositary Receipt (Common Stock)

On April 24, 2026 - Private Advisor Group, LLC filed a 13F-HR form disclosing ownership of 26,488 shares of Takeda Pharmaceutical Company Limited - Depositary Receipt (Common Stock) (DE:TKDA) valued at $418,510 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 22,596 shares of Takeda Pharmaceutical Company Limited - Depositary Receipt (Common Stock). This represents a change in shares of 17.22% during the quarter. The current value of the position is $339,046 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-24 2026-03-31 13F TAKEDA PHARMACEUTICAL SPONSORED ADS 874060205 26,488 3,892 17.22 491 39.20 0.0022
2026-02-17 2025-12-31 13F TAKEDA PHARMACEUTICAL SPONSORED ADS 874060205 22,596 1,277 5.99 352 12.82 0.0016
2025-11-13 2025-09-30 13F TAKEDA PHARMACEUTICAL SPONSORED ADS 874060205 21,319 21,319 312 0.0015
2025-02-03 2024-12-31 13F TAKEDA PHARMACEUTICAL SPONSORED ADS 874060205 0 -12,247 -100.00 0 -100.00
2024-10-22 2024-09-30 13F TAKEDA PHARMACEUTICAL SPONSORED ADS 874060205 12,247 520 4.43 174 15.23 0.0011
2024-08-05 2024-06-30 13F TAKEDA PHARMACEUTICAL SPONSORED ADS 874060205 11,727 -847 -6.74 152 -13.22 0.0010
2024-04-30 2024-03-31 13F TAKEDA PHARMACEUTICAL SPONSORED ADS 874060205 12,574 -6,037 -32.44 175 -34.34 0.0013
2024-02-06 2023-12-31 13F TAKEDA PHARMACEUTICAL SPONSORED ADS 874060205 18,611 -443 -2.32 266 -9.86 0.0021
2023-11-03 2023-09-30 13F TAKEDA PHARMACEUTICAL SPONSORED ADS 874060205 19,054 2,254 13.42 295 13.51 0.0026
2023-08-10 2023-06-30 13F TAKEDA PHARMACEUTICAL SPONSORED ADS 874060205 16,800 16,800 259 0.0023
2023-05-10 2023-03-31 13F TAKEDA PHARMACEUTICAL SPONSORED ADS 874060205 0 -10,629 -100.00 0 0.0000
2023-01-18 2022-12-31 13F TAKEDA PHARMACEUTICAL SPONSORED ADS 874060205 10,629 41 0.39 0 -100.00 0.0000
2022-10-14 2022-09-30 13F TAKEDA PHARMACEUTICAL SPONSORED ADS 874060205 10,588 -159,479 -93.77 137 -94.26 0.0016
2022-07-13 2022-06-30 13F TAKEDA PHARMACEUTICAL SPONSORED ADS 874060205 170,067 35,385 26.27 2,388 23.86 0.0213
2022-05-12 2022-03-31 13F/A-1 TAKEDA PHARMACEUTICAL SPONSORED ADS 874060205 134,682 42,439 46.01 1,928 53.26 0.0148
2022-05-10 2022-03-31 13F TAKEDA PHARMACEUTICAL SPONSORED ADS 874060205 92,243 0 1,258 0.0095
2022-02-10 2021-12-31 13F TAKEDA PHARMACEUTICAL SPONSORED ADS 874060205 92,243 -28,604 -23.67 1,258 -36.43 0.0094
2021-10-14 2021-09-30 13F TAKEDA PHARMACEUTICAL SPONSORED ADS 874060205 120,847 74,973 163.43 1,979 156.35 0.0126
2021-08-12 2021-06-30 13F TAKEDA PHARMACEUTICAL SPONSORED ADS 874060205 45,874 11,745 34.41 772 23.92 0.0067
2021-04-22 2021-03-31 13F TAKEDA PHARMACEUTICAL SPONSORED ADS 874060205 34,129 11,576 51.33 623 51.95 0.0059
2021-04-01 2020-12-31 13F TAKEDA PHARMACEUTICAL SPONSORED ADS 874060205 22,553 22,553 410 0.0043
2020-10-30 2020-09-30 13F TAKEDA PHARMACEUTICAL SPONSORED ADS 874060205 0 -4,790 -100.00 0 -100.00
2020-08-17 2020-06-30 13F TAKEDA PHARMACEUTICAL SPONSORED ADS 874060205 4,790 4,790 86 0.0012
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.